A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases

Clinical trial NCT00699751 · COMPLETED

Trial details

NCT number: NCT00699751
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hormone Refractory Prostate Cancer Bone Metastases

Start date: 2008-06-12
Primary completion: 2011-07-15
Enrollment: 921

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.